2024

1. Adipokines as potential pharmacological targets for immune inflammatory rheumatic diseases: Focus on rheumatoid arthritis, osteoarthritis, and intervertebral disc degeneration

   Pharmacological Research, Vol. 205

2. Aptamer functionalization effect on the interaction of sphingomyelin nanoemulsions with plasma proteins. A thermodynamic approach

   Journal of Molecular Liquids, Vol. 397

3. Bilateral Uveal Melanoma: An Insight into Genetic Predisposition in Four New Unrelated Patients and Review of Published Cases

   Journal of Clinical Medicine, Vol. 13, Núm. 11

4. Biodistribution and pharmacokinetics of [89Zr]-anti-VEGF mAbs using PET in glioblastoma rat models

   International Journal of Pharmaceutics, Vol. 652

5. Corrigendum to "Red Blood Cells Protein Profile Is Modified in Breast Cancer Patients"

   Molecular & cellular proteomics : MCP

6. Differential blood-based biomarkers of subcortical and deep brain small vessel disease

   Therapeutic Advances in Neurological Disorders, Vol. 17

7. Gastric GDF15 levels are regulated by age, sex, and nutritional status in rodents and humans

   Journal of Endocrinological Investigation, Vol. 47, Núm. 5, pp. 1139-1154

8. Genome-wide DNA methylation profiling in tongue squamous cell carcinoma

   Oral Diseases, Vol. 30, Núm. 2, pp. 259-271

9. Human recombinant relaxin-2 (serelaxin) regulates the proteome, lipidome, lipid metabolism and inflammatory profile of rat visceral adipose tissue

   Biochemical Pharmacology, Vol. 223

10. Implantable SDF-1α-loaded silk fibroin hyaluronic acid aerogel sponges as an instructive component of the glioblastoma ecosystem: Between chemoattraction and tumor shaping into resection cavities

    Acta Biomaterialia, Vol. 173, pp. 261-282

11. Modulation of Abundance and Location of High-Mobility Group Box 1 in Human Microglia and Macrophages under Oxygen-Glucose Deprivation

    ACS Pharmacology and Translational Science, Vol. 7, Núm. 3, pp. 680-692

12. Multi-tissue transcriptomics of a unique monozygotic discordant twin case of severe progressive osseous heteroplasia

    Genes and Diseases, Vol. 11, Núm. 3

13. New Perspectives in Neuroprotection for Ischemic Stroke

    Neuroscience

14. Pancreatic cancer biomarkers: A pathway to advance in personalized treatment selection

    Cancer Treatment Reviews, Vol. 125

15. Partial volume correction in longitudinal tau PET studies: is it really needed?

    NeuroImage, Vol. 289

16. Relationships between Patient-Reported Outcome Measures and Clinical Measures in Naïve Neovascular Age-Related Macular Degeneration Patients Treated with Intravitreal Ranibizumab

    Pharmaceuticals, Vol. 17, Núm. 2

17. The Effect of Systemic Parameters and Baseline Characteristics in Short-Term Response Analysis with Intravitreal Ranibizumab in Treatment-Naive Patients with Neovascular Age-Related Macular Degeneration

    Pharmaceutics, Vol. 16, Núm. 1

18. Thrombolytic therapy based on lyophilized platelet-derived nanocarriers for ischemic stroke

    Journal of Nanobiotechnology, Vol. 22, Núm. 1

19. Towards Precision Medicine in Clinical Practice: Alinity C vs. UHPLC-MS/MS in Plasma Aripiprazole Determination

    Pharmaceutics, Vol. 16, Núm. 1

20. Towards precision medicine of long-acting aripiprazole through population pharmacokinetic modelling

    Psychiatry Research, Vol. 333